MEDICINA
Department
Hospital Italiano de Buenos Aires
Buenos Aires, ArgentinaPublications in collaboration with researchers from Hospital Italiano de Buenos Aires (13)
2022
-
Guidelines on the management of mineral and bone metabolism disorders during pregnancy and lactation
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 530-539
2020
-
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 3, pp. 205-215
2018
-
Consensus document on osteoporosis in males
Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 9-16
2017
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367
-
Recommendations on the effect of antidiabetic drugs in bone
Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 1-6
-
Recommended vitamin D levels in the general population
Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 7-14
-
Transancestral mapping and genetic load in systemic lupus erythematosus
Nature Communications, Vol. 8
2015
-
Multiplex Real-Time PCR Assay Using TaqMan Probes for the Identification of Trypanosoma cruzi DTUs in Biological and Clinical Samples
PLoS Neglected Tropical Diseases, Vol. 9, Núm. 5
2013
-
Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression
PLoS Genetics, Vol. 9, Núm. 10
2009
-
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus
Human Molecular Genetics, Vol. 18, Núm. 19, pp. 3739-3748
-
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans
Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923
2007
-
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus
Arthritis and Rheumatism, Vol. 56, Núm. 4, pp. 1234-1241
1999
-
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study
Osteoporosis International, Vol. 9, Núm. 5, pp. 461-468